Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials

被引:26
|
作者
Xu, Lijuan [1 ]
Wan, Xuesi [1 ]
Huang, Zhimin [1 ]
Zeng, Fangfang [2 ]
Wei, Guohong [1 ]
Fang, Donghong [1 ]
Deng, Wanping [1 ]
Li, Yanbing [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Sch Publ Hlth, Guangdong Prov Key Lab Food Nutr & Hlth, Guangzhou, Guangdong, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 04期
关键词
GLOMERULAR-FILTRATION-RATE; TYPE-2; DIABETIC-PATIENTS; SECONDARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; NONDIABETIC NEPHROPATHIES; DOUBLE-BLIND; D-RECEPTOR; PARICALCITOL; ALBUMINURIA; PROTEINURIA;
D O I
10.1371/journal.pone.0061387
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background and Objectives: Recent studies have supported a role for both newer and more established vitamin D compounds in improving proteinuria, although systematic evaluation is lacking. Furthermore, concerns remain regarding the influence of vitamin D on the progression of renal function. We analyzed the efficacy and safety of vitamin D in non-dialysis patients and compared the use of newer versus established vitamin D compounds by performing a meta-analysis of randomized controlled trials. Design: A literature search of PubMed (1975 to September, 2012), EMBASE.com (1966 to September, 2012) and Ovid EBM Reviews (through September, 2012) was conducted. Results: Eighteen studies were eligible for final inclusion; of these, six explored the effects of vitamin D on proteinuria, twelve studied the effects of supplementation on renal function, and fifteen discussed the incidence of hypercalcemia. Compared to the placebo or no interference, both the newer and established vitamin D sterols reduced proteinuria to a similar extent (RR, 2.00; 95% CI, 1.42 to 2.81). No decrease in the glomerular filter rate was observed (SMD, -0.10; 95% CI, -0.24 to 0.03), and the risk for dialysis initiation was 1.48 (95% CI, 0.54 to 4.03) with vitamin D treatment. Additionally, there was an increased risk of hypercalcemia for patients treated with either newer or established vitamin D compounds as compared with the controls (RR, 4.78; 95% CI, 2.20 to 10.37). The head-to-head studies showed no differences in the effects of either newer or established compounds on proteinuria or the risk of hypercalcemia. No serious adverse events were associated with the administration of vitamin D. Conclusions: Vitamin D therapy appears to decrease proteinuria and have no negative influence on renal function in non-dialysis patients. But the occurrence of hypercalcemia should be evaluated when vitamin D is provided. No superiority for newer versus established vitamin D analogue is found.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis
    Bover, Jordi
    Gunnarsson, Joel
    Csomor, Philipp
    Kaiser, Edelgard
    Cianciolo, Giuseppe
    Lauppe, Rosa
    CLINICAL KIDNEY JOURNAL, 2021, 14 (10) : 2177 - 2186
  • [2] Active vitamin D increases the risk of hypercalcaemia in non-dialysis chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis
    Cozzolino, Mario
    Bernard, Laurence
    Csomor, Philipp A.
    CLINICAL KIDNEY JOURNAL, 2021, 14 (11) : 2437 - 2443
  • [3] Vitamin D supplementation for the improvement of vascular function in patients with chronic kidney disease: a meta-analysis of randomized controlled trials
    Dou, Ding
    Yang, Bing
    Gan, Hongqiao
    Xie, Dengpiao
    Lei, Huangwei
    Ye, Naijing
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (05) : 851 - 858
  • [4] NUTRITIONAL OR ACTIVE VITAMIN D FOR THE CORRECTION OF MINERAL METABOLISM ABNORMALITIES IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS?
    Stancu, S.
    Chiriac, C.
    Maria, D. T.
    Mota, E.
    Mircescu, G.
    Capusa, C.
    ACTA ENDOCRINOLOGICA-BUCHAREST, 2018, 14 (04) : 505 - 513
  • [5] Cinacalcet plus vitamin D versus vitamin D alone for the treatment of secondary hyperparathyroidism in patients undergoing dialysis: a meta-analysis of randomized controlled trials
    Xu, Jun
    Yang, Yan
    Ma, Liang
    Fu, Ping
    Peng, Hongying
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (11) : 2027 - 2036
  • [6] Impact of Vitamin D on the Occurrence and Development of Intestinal Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Liu, Jiewei
    Wang, Yue
    Zou, Yanhong
    Li, Chunyu
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (12) : 2247 - 2258
  • [7] The treatment efficacy of vitamin D3 for heart failure patients: a meta-analysis of randomized controlled trials
    Chen, Hongsheng
    Chen, Muhu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (12): : 13196 - 13202
  • [8] Biotic Supplements in Patients With Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials
    Liu, Jing
    Zhong, JianYong
    Yang, HaiChun
    Wang, DongQin
    Zhang, Ying
    Yang, YuMeng
    Xing, GuoLan
    Kon, Valentina
    JOURNAL OF RENAL NUTRITION, 2022, 32 (01) : 10 - 21
  • [9] Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials
    Palmer, Suetonia C.
    Nistor, Ionut
    Craig, Jonathan C.
    Pellegrini, Fabio
    Messa, Piergiorgio
    Tonelli, Marcello
    Covic, Adrian
    Strippoli, Giovanni F. M.
    PLOS MEDICINE, 2013, 10 (04)
  • [10] Vitamin D Supplementation in the Treatment of Chronic Heart Failure: A Meta-analysis of Randomized Controlled Trials
    Jiang, Wei-Long
    Gu, Hai-Bo
    Zhang, Yu-Feng
    Xia, Qing-Qing
    Qi, Jia
    Chen, Jian-Chang
    CLINICAL CARDIOLOGY, 2016, 39 (01) : 56 - 61